| Aarti Pharmalabs Limited |
|
Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
| Accuracy Shipping Limited |
|
Accuracy Shipping Limited has informed the Exchange regarding Resignation of Mr. Raj Kumar Poddar as Non- Executive Independent Director of the company w.e.f. Jun 12, 2026.
|
| Advent Hotels International Limited |
|
Karim Gulamali Morani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
| Advanced Enzyme Technologies Limite |
|
Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
|
| Aequs Limited |
|
Aequs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
| Affle 3i Limited |
|
Affle 3i Limited has submitted to the Exchange a copy of Disclosure under Regulation 31 (1) SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 - Revised
|
| Authum Investment & Infrastructure |
|
Alpana Dangi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
| Ajanta Pharma Limited |
|
Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference
|
| Ansal Properties & Infrastructure L |
|
The Company has informed the stock exchanges that the 53rd meeting of the committee of creditors of Fernhill Project of the Company situated at District Gurgaon, Haryana, is scheduled to be held on the 15th June, 2026.
|
| Alembic Pharmaceuticals Limited |
|
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.".
|